— LISTEE'S SPOTLIGHT —

Dr. Sam Sammane, the founder and chief executive officer of THEOSYM, is regarded as a pioneer in applying artificial intelligence (AI) to life sciences and the pharmaceutical industry. THEOSYM specializes in developing AI solutions and AI-driven tools to enhance research, data analysis and decision-making processes in laboratories and pharmaceutical environments. As the organization’s chief executive officer, Dr. Sammane conducts interviews, hosts podcasts, and is involved in the development and marketing teams. Notably, he recently launched a YouTube channel in 2023 to share his work, and he has garnered 150,000 subscribers thus far. Concurrently, he is a co-founder of Olio Pharmaceuticals with former experience as a C-suite executive at Tentamus Group, American Testing Labs, Labofine, SBI Solutions and Garmen Laboratory. Remarkably, in 2023, Dr. Sammane authored “The Singularity of Hope: Humanity’s Role in an AI-Dominated Future,” which achieved best-seller status on Amazon and received a five-star review from the Book Review organization. He has also published more than 40 peer-reviewed academic papers. Highly educated, he holds a Bachelor of Applied Science and a master’s degree in applied physics, as well as a master’s degree and Doctor of Philosophy in nanotechnology, all from Université Joseph Fourier in Grenoble, France.